Seller review · costs and terms
AVARA Rx review
AVARA Rx lists treatment starting amounts but separates branded medication from its consultation membership. Manual renewal and prescription-processing cutoffs need a product-specific agreement.
By Jenna Pratt, consumer-access reporter · Updated October 2026
Price
Confirm product and price
Itemized bill
AVARA Rx
Totals are our arithmetic from the seller’s published figures. Extra fees unconfirmed: the seller states no amount for membership or medical review or delivery or laboratory testing. Confirm these charges and the medication price before paying.
The bill, in one line
Compare a written quote for the chosen treatment. The catalog’s starting figures do not establish the same supply period or complete recurring medicine bill.
AVARA Rx organizes clinical review and pharmacy fulfillment through independent parties, offering a mix of compounded wellness treatments, generic metabolic programs and branded GLP-1 consultation services. A buyer needs the exact product and agreement rather than one general platform price, particularly because the FAQ describes manual monthly renewal that can provide control over future purchases. Other policy language refers to subscriptions, so confirm the arrangement before relying on either description.
On their product pages, NAD+ starts at $249, sermorelin at $299 and glutathione at $199. The exact supplied period and full dose schedule are not clearly assigned to each figure. Generic GLP program cards and the promotional banner show additional starting amounts without resolving that detail. Branded GLP-1 access instead has a $149 monthly care membership that explicitly excludes medicine, so those consultation fees should not be presented as drug prices. Testing and the complete pharmacy total still need confirmation for the selected plan.
Fees outside the headline
Membershipnot published
Ordinary compound-program fee scope is unclear; branded plans have a separate149monthly care membership.
Read October 2026
Medical reviewnot published
Quarterly care and monthly review are described without one universal compound-program fee schedule.
Read October 2026
Deliverynot published
A universal delivery charge or included allowance is not established.
Read October 2026
Laboratory testingnot published
A universal testing charge is not established on the public plan pages.
Read October 2026
See AVARA Rx’s current price
Check the seller’s own page before you pay.
The fine print
- Prepay
- The expanded ordering FAQ describes a monthly renewal notification and patient-initiated payment after provider review, expressly denying automatic monthly debit. That does not establish the supply length or price of every product, and it should be reconciled with the separate returns page’s subscription language. Ask whether a minimum term, prepaid supply or later installment applies, keeping any first-month promotional code separate from the chosen offer’s ordinary quote.
- Cancellation
- Contact support promptly to change or cancel an order before pharmacy processing. The FAQ says changes may become unavailable after submission, fulfillment or shipping, while the returns page mentions account cancellation before shipment and final sales once a charged package reaches the carrier. Obtain confirmation of the current order’s cutoff because those descriptions differ, and the thirty-day return policy concerns unopened nonprescription items rather than a right to return a filled prescription. Wrong, damaged or lost orders have a separate support process.
- Shipping
- The FAQ describes approval followed by pharmacy fulfillment and tracking, without establishing one universal delivery fee for every treatment. Clarify the returns policy’s nonrefrigeration statement against the actual injectable prescription, confirming pharmacy handling instructions, shipment method and response to delays rather than applying generic wording to every preparation.
Worth it, and what to watch
Worth it
- Manual renewal is described explicitly
- Branded medicine is separated from the consultation fee
- Order-processing limits are stated publicly
Watch for
- Treatment starting amounts lack a clear universal supply period
- Refund and cancellation cutoffs use different wording
- The dispensing pharmacy needs confirmation
- Routine testing and delivery costs remain unclear
- Buy here if
- A shopper willing to confirm the selected treatment, manual payment process and pharmacy cutoff in writing.
- Look elsewhere if
- Someone treating a care membership or promotional banner as the complete medication bill.
FAQ
3 questionsDoes the consultation membership buy the branded drug?
No. The branded pages charge medication separately after clinical approval.
Are prescription returns covered by the thirty-day policy?
That section concerns unopened nonprescription products. Filled prescriptions have tighter restrictions.
Does monthly renewal prove every product price is monthly?
No. Obtain the supply period and exact amount for the selected preparation.
Price it at AVARA Rx
Every figure above was read from AVARA Rx’s own pages. The current one is a click away.
Questions the research answers
Other sellers we have priced
| Nex Gen Health Rx | $57.32/mo, Glutathione injection |
|---|---|
| Contour Health | $60/mo, NAD+ injection |
| Collective | $76/mo, Semaglutide injection |
| Avono Health | $79/mo, Semaglutide injection |
| Lean Meds | $79/mo, Semaglutide injection |
| RxPepsDirect | $80 per vial, Sermorelin injection |
| Enhanced | $89/mo, Semaglutide injection |
| Citizen Meds | $91/mo, NAD+ injection |
Where every figure comes from
- Payments and policies: Current treatment catalog
- Payments and policies: NAD+ injection
- Payments and policies: Sermorelin compound
- Payments and policies: Glutathione description
- Payments and policies: Branded consultation fee scope
- Payments and policies: Oral branded preparation
- Payments and policies: Manual renewal and order FAQ
- Payments and policies: Prescription returns and shipping caveats
- Payments and policies: Care network and legal terms
- Payments and policies: Privacy notice inconsistency